Search Results
Site Search
Jeff Meeusen, Ph.D., Discusses New Blood Test on "Voice of America" - Insights
Jeff Meeusen, Ph.D., a clinical chemist and Co-Director of Cardiovascular Laboratory Medicine at Mayo Clinic, discussed Mayo Clinic's new blood test that helps combat the leading cause of death in the U.S. on Voice of America.
Mayo Clinic Laboratory and pathology research roundup: September 5 - Insights
This week's research roundup feature: 16S rRNA gene PCR/Sequencing of heart valves for diagnosis of infective endocarditis in routine clinical practice.
Mayo Clinic Laboratory and pathology research roundup: August 22 - Insights
This week's research roundup feature: Association of plasma biomarkers of Alzheimer Disease with cognition and medical comorbidities in a biracial cohort.
Mayo Clinic Laboratory and pathology research roundup: August 15 - Insights
This week's research roundup feature: Gain-of-function mutant p53 together with ERG proto-oncogene drive prostate cancer by beta-catenin activation and pyrimidine synthesis.
Early-Onset IBD: Genetic Testing and Clinical Applications - Insights
Identification of early-onset IBD patients may enable tailored treatment and surveillance plans. With over 50 genes implicated in early-onset IBD, genetic testing should be included in the workup of children under the age of six with IBD....
Comprehensive panels - Insights
Learn how our in-depth genetic testing can determine whether a cancer is hereditary in origin for individuals with a family history of cancer.
Learn more about how our flexible lab space and expert staff can help you meet your diagnostic needs.
Mayo Clinic Laboratories’ genetic counselors are experts on heritable illness who provide a wealth of knowledge to guide appropriate testing utilization and interpret results.
Learn more about how Mayo Clinic Laboratories’ genetic gastroenterology tests can provide diagnostic clarity across a range of inherited GI disorders.
New tests launched in September - Insights
In September 2022, Mayo Clinic Laboratories announced ten new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Necrotizing Autoimmune Myopathy Testing - Mayo Clinic Laboratories
We offer advanced testing of the most pertinent antibodies associated with IMNM on a sensitive immunofluorescence-based assay providing fast results for patients.
Answers to the most commonly asked questions on shipping supplies and requirements, turn-around-times, and billing, among others.
Pharmaceutical solutions - Insights
We believe the pharmaceutical industry and clinical research partners can improve global health through innovative drug discovery and development — and that you deserve the best reference lab partner at your side. Mayo Clinic BioPharma...
Testing Options for Patients with Chronic Diarrhea: A Focus on Bile Acid Malabsorption - Insights
A new serum test for bile acid malabsorption. Descriptions illustrate how the test can be used as a screening test and as a tool for therapeutic action.
Mission not impossible: Overcoming challenging pediatric draws - Insights
This “Phlebotomy Webinar” covers real-life challenging scenarios that arise in the clinical setting. Four unique case studies are presented, and suggestions are discussed on how to help and respond in these situations to support the...
Autoimmune Encephalitis Diagnosis and Misdiagnosis - Insights
PACEIn this month’s “Virtual Lecture” Eoin Flanagan, M.D., B.Ch., reviews how to diagnose autoimmune encephalitis, what to watch that may suggest a different diagnosis, discuss neural autoantibodies interpretation and putting test results...
Mayo Clinic Laboratories’ targeted testing for opioids uses high-resolution mass spectrometry to detect 33 different opioids.
Education on this topic decreases misdiagnosis and the possibility of misinterpreting the comments provided by the reporting laboratories.
Quantitative Adenovirus Assay Better Informs Post-Transplant Care: Joseph Yao, M.D. - Insights
Joseph Yao, M.D., explains how Mayo Clinic Laboratories' new quantitative assay (Mayo ID: ADVQU) goes beyond qualitative testing to evaluate transplant patients for adenovirus infection. Adenovirus can cause life-threatening disease in...
Labile Copper Test Enhances Evaluation for Wilson's Disease: Joshua Bornhorst, Ph.D. - Insights
Joshua Bornhorst, Ph.D., explains how Mayo Clinic Laboratories' labile copper assay (Mayo ID: LBCS) improves upon standard blood tests for Wilson's disease. The new assay measures not just overall copper but also the fraction of copper that...
Helicobacter pylori - Insights
Find out why timely, accurate diagnosis of H. pylori is critical for improving patients’ gastrointestinal health and preventing further harm.
Autoimmune GI Dysmotility - Mayo Clinic Laboratories
Identifying GI dysmotility as autoimmune-mediated is extremely important because patients treated with immunotherapy can see a dramatic improvement, going from persistent nausea, vomiting, and weight loss to feeling normal within a few...
Sarcoma NGS Testing - Mayo Clinic Laboratories
n order to aid in the diagnosis for a wide range of tumors, our sarcoma NGS panel includes fusions in 138 individual genes.
New tests launched in November - Insights
Mayo Clinic Laboratories launched the following three tests in November.
The Right Medication for You: Pharmacogenomics Testing at Mayo Clinic - Insights
How Your Genes Determine which Medications Work Best for You The drugs available today to treat diseases are powerful agents that work as intended for
Beyond Q-tips: The swabbing guide for SARS-CoV-2 - Insights
This "Phlebotomy Webinar" will discuss the various types of swabs that can be used to collect specimens for SARS-CoV-2 molecular testing.
Mayo Clinic Laboratories’ targeted benzodiazepine testing uses high-resolution mass spectrometry to identify 27 different benzodiazepines and metabolites in the urine.
Introduction to Cost of Quality in the Laboratory - Insights
This "Phlebotomy" webinar will provide an introduction to cost of quality. The main components of the presentation will include discussions on the cost of attaining quality and the cost of poor quality.
Comprehensive panels - Insights
Check out Mayo Clinic Laboratories’ comprehensive pharmacogenomic panels, which identify genetic variations associated with treatment response.
Purine and pyrimidine metabolism disorders - Insights
Check out how Mayo Clinic Laboratories’ genetic testing can help to diagnose and monitor patients affected by purine and pyrimidine metabolism disorders.
Malabsorption panel - Insights
Mayo Clinic Laboratories, which is integrated with the clinical gastroenterology practice at Mayo Clinic, understands the worry patients and their loved ones feel while awaiting test results. To expedite and streamline the diagnostic...
Pioneering Research in Autoimmune Neurology: Vanda Lennon, M.D., Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by Vanda Lennon, M.D., Ph.D., founder of the Neuroimmunology Laboratory and now...
Mayo Clinic Laboratory and pathology research roundup: April 11 - Insights
This week's Research Roundup feature: A stress-induced cilium-to-PML-NB route drives senescence initiation.
Necrotizing Autoimmune Myopathy [Test in Focus] - Insights
Necrotizing autoimmune myopathy (NAM) is a serious but rare muscle disease strongly associated with autoantibodies to either the protein signal recognition particle (SRP) or the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase...
Pediatric Phlebotomy with Pain Management: Creating an Optimal Experience - Insights
This “Phlebotomy” webinar reviews: Having a medical procedure or a lab draw can be fearful for children. Even if it is their first time or they have had a bad past experience, there are ways to make these procedures easier for children.
Alpha-gal testing [Test in Focus] - Insights
Joshua Bornhorst, Ph.D., associate director of Mayo Clinic's Clinical Immunoassay Lab, explains how humans can develop an allergy to the alpha-gal molecule, and he describes a new allergen antibody test that can be used to detect it. Dr....
Comprehensive neuromuscular panel - Insights
Find out how the emergence of advanced molecular testing technologies has enhanced the detection of inherited neuromuscular disorders.
Learn how our muscular dystrophy genetic testing can help patients access variant-specific therapies and determine eligibility for clinical trials.
Bone and Soft Tissue Pathology Services at Mayo Cinic Laboratories
At Mayo Clinic, we excel in our approach to work collaboratively with radiology, surgery, and clinical practice to bring the highest quality.
Capillary Puncture vs. Venipuncture: Advantages and Limitations to Using Capillary Blood - Insights
This “Phlebotomy Webinar” will review the physiologic differences between capillary and venous blood, and discuss advantages and limitations to each specimen type.
Featured new tests in quarter two of 2025 - Insights
In the second quarter of 2025, Mayo Clinic Laboratories expanded its test catalog with several innovative new tests.
They Did "WHAT?!" Capturing Patient Experience to Increase Patient Satisfaction - Insights
This “Phlebotomy” webinar will discuss how a patient’s “experience” is the entirety of all the interactions that person has had within the health care system. Each member of a health care team plays a role in enhancing patient satisfaction,...
Dr. Morice joins Becker’s Healthcare to discuss how a platform approach to diagnostics and strategic collaborations enhances outcomes.
The discovery of Kelch like protein 11 (KLHL11) IgG as a specific biomarker of neurological autoimmunity associated testicular germ cell tumor.
Darci Block, Ph.D., discusses saliva testing in AACC's Clinical Laboratory News - Insights
Saliva testing has emerged as a viable option for obtaining rapid, reliable test results during the COVID-19 pandemic. Mayo Clinic’s Dr. Darci Block considers how this type of testing may expand beyond the pandemic, and the obstacles in its...
Mayo Clinic Laboratories releases new, first-to-U.S.-market pregnancy risk assessment - Insights
Mayo Clinic Laboratories now offers the first preeclampsia-specific test (Mayo ID: PERA) that can be used to stratify patients into low or high-risk categories, indicating whether a patient is at risk for developing preeclampsia with severe...
CPT codes and LOINC update: February 2024 - Insights
This page includes updates posted to Mayo Clinic Labs during the month of February.
CPT codes and LOINC update: August 2021 - Insights
The following list includes updates posted to mayocliniclabs.com during the month of August.
CPT codes and LOINC update: January 2021 - Insights
The following list includes updates posted to mayocliniclabs.com during the month of January.
CPT codes and LOINC update: March 2021 - Insights
The following list includes updates posted to mayocliniclabs.com during the month of March.